Transcriptomics

Dataset Information

0

Splice-switching antisense oligonucleotide controlling tumor suppressor REST is a novel therapeutic medicine for neuroendocrine cancer

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE245707 | GEO | 2024/07/02

REPOSITORIES: GEO

Json Xml

Similar Datasets

Unknown Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation.
| S-EPMC8583451 | biostudies-literature
Unknown Splice-switching antisense oligonucleotides as therapeutic drugs.
| S-EPMC5001604 | biostudies-literature
Unknown A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer.
| S-EPMC6527545 | biostudies-literature
Unknown Development of therapeutic splice-switching oligonucleotides.
| S-EPMC4098814 | biostudies-literature
Unknown Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms.
| S-EPMC2835096 | biostudies-literature
Unknown Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides.
| S-EPMC8302632 | biostudies-literature
Unknown Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides.
| S-EPMC6954394 | biostudies-literature
Unknown Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1.
| S-EPMC5155325 | biostudies-literature
Unknown Delivery is key: lessons learnt from developing splice-switching antisense therapies.
| S-EPMC5412803 | biostudies-literature
Unknown Welcome to the splice age: antisense oligonucleotide-mediated exon skipping gains wider applicability.
| S-EPMC4811139 | biostudies-literature